Inovio Pharmaceuticals (INO) $9M Grant Formalizes Entry Into Coronavirus Virus Solution Mix - RBC
Tweet Send to a Friend
RBC Capital analyst Gregory Renza reiterated an Outperform rating and $7.00 price target on Inovio Pharmaceuticals (NASDAQ: INO) as the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
